Robert Michel
Until Robert L. Michel came along and founded The Dark Intelligence Group (DIG) two decades ago, the clinical laboratory industry and the anatomic pathology profession lacked a trustworthy source for information about the management and operations of medical laboratories. From its inception in 1995, The Dark Report quickly became the “go to” source of industry intelligence, innovations in lab management, and strategic market analysis.
This excellence in reporting has earned recognition from his peers. For example, twice Michel and The Dark Report have won national awards for best investigative reporting by the Specialty Information Publishers Association. In 2005, the award was for Michel’s coverage about how the anatomic pathology condominium laboratories (pod labs) operated by urologists and gastroenterologists came to be, who operated them, and how these owners marketed the AP condo labs to other physician groups. In 2009, Michel’s award for best investigative reporting resulted from his published interviews with Quest Diagnostics Incorporated when the company admitted that, for a period of 18 months, it had been reported inaccurate Vitamin 25(OH) D results because of problems with its laboratory-developed test methodology. The Dark Report’s story was picked up by The New York Times and was in the national news cycle for several days.
In his role as Editor-in-Chief, Michel brought unique capabilities to DIG and The Dark Report. His management training and diverse business experience—along with his skills as a concise writer and analyst—proved to be a winning combination for readers of The Dark Report. For that reason, Michel’s story has many intriguing elements.
Immediately prior to founding DIG, he had served in several executive positions for Nichols Institute based in Portland, Oregon, and San Juan Capistrano, California. This was during the time that Nichols Institute was an independent public lab company with annual revenues of about $280 million (prior to its acquisition by MetPath, Inc., now Quest Diagnostics Incorporated). He traveled extensively to many of the clinical lab business units owned by Nichols Institute in different regions of the United States and played a role in formulating effective market strategies in response to the emergence of closed-panel HMOs, capitated pricing, and full-risk managed care contracts, among other successful management initiatives.
Prior to his service at Nichols Institute, Michel served at three different Fortune 100 companies. These were Procter & Gamble, Centex Corporation, and Financial Corp. of America. Each was an opportunity to master new management techniques and apply them in different industries. Between these positions, he gained experience as an entrepreneur, having founded a real estate development firm and a general contracting company in the Southeastern United States.
Robert Michel earned a Bachelor of Arts degree in Economics at the University of California, Los Angeles, where he played rugby, a sport he participated in for another 22 years. He is a native of California and grew up in Santa Ana.
Articles by Robert Michel
Kaiser Reports Huge Loss, Many HMOs Losing Money
From the Volume V No. 3 – March 2, 1998 Issue
CEO SUMMARY: Poor financial performance of many managed care plans is bad news for clinical laboratories. Those insurance plans losing money find it tough to increase reimbursement for laboratory tests. Financial struggles of the health insurance industry should be closely watched for its…
Catholic Healthcare West, Tenet Form Joint Venture
From the Volume V No. 3 – March 2, 1998 Issue
CEO SUMMARY: This consolidation initiative brings together the resources of both hospital operators. The objective of the partnership is to more efficiently align services in California’s San Joaquin Valley. This is a proactive step that anticipates further reductions in reimbursement a…
AmeriPath, SmithKline, Unilab, IMPATH, LabOne, Prudential/SBCL
From the Volume V No. 3 – March 2, 1998 Issue
AMERIPATH REPORTS EARNINGS, NEW PURCHASE AmeriPath, Inc. of Riviera Beach, Florida announced its 1997 financial performance. For the year, company revenues totaled $108.4 million. On February 17, the company also disclosed the acquisition of Anatomic Pathology Associates (A…
“March 2, 1998 Intelligence: Late Breaking Lab News”
From the Volume V No. 3 – March 2, 1998 Issue
An interesting executive shuffle is under way at Quest Diagnostics Incorporated. James D. Chambers was promoted to Senior Vice President, Marketing and Business Development. He will report directly to CEO Ken Freeman. Chambers will assume many of the duties handled by Don Hardison, J…
Automated Pap Screening Gains Recommendation
From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Automated cytology technology received a big boost when the FDA’s advisory panel voted to recommend that the FDA approve, with conditions, NeoPath’s AutoPap® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter….
Neuromedical’s PAPNET® Undergoing Enhancement
From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Financial pressures and a falling stock price impelled Neuromedical Systems, Inc. to revamp its sales and marketing plan for the PAPNET® System. During 1998, expect a new sales approach that supports a product with enhanced capabilities. Neuromedical is developing overseas m…
Automated Cytology Technology To Come Into Its Own In 1998
From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMAR…
SmithKline May Merge With Glaxo Wellcome
From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKline’s clinical laboratory division in the merger with Glaxo…
“February 9, 1998 Intelligence: Late Breaking Lab News”
From the Volume V No. 2 – February 9, 1998 Issue
Brian Carr and Haywood Cochrane’s Pathology Consultants of America (PCA) is wasting no time. On January 19 the Nashville-based company announced the formal launch of operations. (See TDR, January 19, 1998.) This was followed by another announcement 15 days later that PCA h…
3rd Annual War College Highlights Managed Care
From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Laboratory executives seeking ways to survive and thrive with managed care contracts will find innovative strategies at this year’s EXECUTIVE WAR COLLEGE on Laboratory Management in New Orleans on May 12-13. Also featured are powerful case studies that define effective mana…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized